Smith & Nephew plc (NYSE:SNN) – Research analysts at Northcoast Research issued their Q1 2019 earnings per share estimates for shares of Smith & Nephew in a research report issued on Monday. Northcoast Research analyst D. Keiser anticipates that the medical equipment provider will post earnings per share of $0.00 for the quarter. Northcoast Research also issued estimates for Smith & Nephew’s Q2 2019 earnings at $1.00 EPS, Q3 2019 earnings at $0.00 EPS and Q4 2019 earnings at $1.09 EPS.
Several other research analysts have also recently commented on SNN. Zacks Investment Research raised shares of Smith & Nephew from a “sell” rating to a “hold” rating in a report on Wednesday, February 7th. Canaccord Genuity reaffirmed a “buy” rating on shares of Smith & Nephew in a report on Thursday, February 8th. ValuEngine cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday. JPMorgan Chase & Co. raised shares of Smith & Nephew from a “neutral” rating to an “overweight” rating in a report on Thursday, January 25th. Finally, Morgan Stanley cut shares of Smith & Nephew from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. Five research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $44.00.
Large investors have recently made changes to their positions in the stock. Bessemer Group Inc. increased its stake in Smith & Nephew by 400.2% in the third quarter. Bessemer Group Inc. now owns 2,781 shares of the medical equipment provider’s stock valued at $102,000 after acquiring an additional 2,225 shares during the last quarter. Icon Wealth Partners LLC bought a new stake in shares of Smith & Nephew during the fourth quarter worth $120,000. SeaCrest Wealth Management LLC bought a new stake in shares of Smith & Nephew during the fourth quarter worth $121,000. Steward Partners Investment Advisory LLC bought a new stake in shares of Smith & Nephew during the fourth quarter worth $126,000. Finally, Lbmc Investment Advisors LLC bought a new stake in shares of Smith & Nephew during the third quarter worth $206,000. 6.59% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Smith & Nephew plc Expected to Earn Q1 2019 Earnings of $0.00 Per Share (SNN)” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/13/smith-nephew-plc-expected-to-earn-q1-2019-earnings-of-0-00-per-share-snn.html.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.